Evaluation of bacteriochlorophyll-reconstituted low-density lipoprotein nanoparticles for photodynamic therapy efficacy in vivo
about
Hepatoblastoma: A Need for Cell Lines and Tissue Banks to Develop Targeted Drug TherapiesPhotodynamic Efficiency: From Molecular Photochemistry to Cell DeathCan nanotechnology potentiate photodynamic therapy?Modular nanotransporters: a multipurpose in vivo working platform for targeted drug delivery.Shining light on nanotechnology to help repair and regeneration.Multimodal bacteriochlorophyll theranostic agent.Near-infrared fluorescent imaging of metastatic ovarian cancer using folate receptor-targeted high-density lipoprotein nanocarriers.In vivo studies of nanostructure-based photosensitizers for photodynamic cancer therapy.Learning from biology: synthetic lipoproteins for drug delivery.Lipoprotein-Related and Apolipoprotein-Mediated Delivery Systems for Drug Targeting and Imaging.Magnetic/NIR-thermally responsive hybrid nanogels for optical temperature sensing, tumor cell imaging and triggered drug release.Low-density lipoprotein-mediated delivery of docosahexaenoic acid selectively kills murine liver cancer cellsElucidating the structural organization of a novel low-density lipoprotein nanoparticle reconstituted with docosahexaenoic acid.Nanotechnology for photodynamic therapy: a perspective from the Laboratory of Dr. Michael R. Hamblin in the Wellman Center for Photomedicine at Massachusetts General Hospital and Harvard Medical School.Biomimetics: reconstitution of low-density lipoprotein for targeted drug delivery and related theranostic applications.Synthesis and characterization of a new natural product analog, 132-173-bacteriochlorophyllone aSynthesis and Development of Lipoprotein-Based Nanocarriers for Light-Activated Theranostics
P2860
Q26751517-6755A204-FD4F-40E1-B308-93489D5CB8CFQ26786242-72CF21D3-59A2-4EA9-888B-4402133CBE61Q28388084-D7C76EFD-21C7-4A14-A4C6-D87085AA7F6FQ34162031-92827713-A8E2-4457-B9CA-F617B5D400FCQ34404413-A351085B-2701-4372-B3E3-26715236DA88Q35224467-665447A6-365E-4B1B-8D9A-D55F47BF55D5Q36840545-AA81E378-78D8-4E1F-87A9-046AAC3E9D6CQ38244010-88C0F5CC-6869-4CA3-91A8-9215E19A2AC3Q38262882-4A760DA3-4E7E-45E4-BF11-A8E12729764EQ38548184-25BAEA10-E0F9-4C3E-81E1-3649743295FCQ38954354-918CD8AC-522E-42FB-AAA0-249175F9D693Q39036813-AAD734BD-5031-47DB-8ACA-CF07B3FDD729Q41598467-A1514FE8-D67F-4C3A-BD8D-8E63FCB27644Q41823406-47A936DA-8224-4B2C-AF51-C944BC5A05B1Q47379259-A64F42D9-5CE6-4AB0-92AD-9782CF61F606Q59159035-6DC4AFDA-D926-4469-833E-EA5EEF8E9B39Q59159093-55E2EE3F-E860-460B-BE6E-2DDDAAF92D4F
P2860
Evaluation of bacteriochlorophyll-reconstituted low-density lipoprotein nanoparticles for photodynamic therapy efficacy in vivo
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Evaluation of bacteriochloroph ...... namic therapy efficacy in vivo
@ast
Evaluation of bacteriochloroph ...... namic therapy efficacy in vivo
@en
type
label
Evaluation of bacteriochloroph ...... namic therapy efficacy in vivo
@ast
Evaluation of bacteriochloroph ...... namic therapy efficacy in vivo
@en
prefLabel
Evaluation of bacteriochloroph ...... namic therapy efficacy in vivo
@ast
Evaluation of bacteriochloroph ...... namic therapy efficacy in vivo
@en
P2093
P2860
P356
P1433
P1476
Evaluation of bacteriochloroph ...... namic therapy efficacy in vivo
@en
P2093
Britton Chance
Diane E Marotta
E Paul Wileyto
Elizabeth Rickter
Ian Corbin
Jerry D Glickson
Theresa M Busch
Weiguo Cao
P2860
P304
P356
10.2217/NNM.11.8
P50
P577
2011-04-01T00:00:00Z